StockData
BillionToOne, Inc. logo

BillionToOne, Inc. (BLLN) stock

BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/30
$90.20−1.34 (-1.46%)

Close on Nov 19, 2026Market cap $4.26BP/E –Yield –

BillionToOne free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

BillionToOne's free cash flow for the twelve months ending Sep 30, 2026 was $33.90M. For fiscal 2025 it was $15.71M.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$15.71M–
FY2024Dec 31, 2024-$46.78M–
FY2023Dec 31, 2023-$59.85M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$8.60M+9.2%
Q2 FY2026Jun 30, 2026$5.09M–
Q1 FY2026Mar 31, 2026$10.96M+3842.1%
Q4 FY2025Dec 31, 2025$9.26M–
Q3 FY2025Sep 30, 2025$7.87M–
Q2 FY2025Jun 30, 2025-$1.69M–
Q1 FY2025Mar 31, 2025$278.00K–
Q4 FY2024Dec 31, 2024-$10.50M–

More BillionToOne figures

See a number that looks wrong?